Uncommon Equities provides company-paid research for promising public small and microcap companies that need to have their stories told in a balanced, professional manner.
The co-founders are Paul Resnik, CFA, Director of Research and Senior Research Analyst, and Denise Resnik, Senior Research Analyst.
Paul Resnik is a Chartered Financial Analyst and Registered Supervisory Analyst with over 40 years of research and management experience in major brokerage firms and independent research firms. Mr. Resnik is the President of Resnik Asset Management Co., Inc, a registered investment advisor, which has been managing large cap equity portfolios for high net worth investors since 1995. He graduated from Hobart College with a Bachelor of Arts in Economics.
Denise Resnik principally conducts financial analysis of emerging, biotech companies capitalizing on her extensive consulting career in the pharmaceutical industry. Her industry experience spans both large global pharmaceutical companies and smaller biotech companies in the area of clinical research. Ms. Resnik holds a Bachelor of Arts degree in Biology from Clark University and a Masters of Science degree in Pharmacology from Northeastern University.
81 years old and counting.
PhD in Biochem, minor Genetics, UNC Chapel Hill.
MS Analytical Chem, St. Joseph's. (evening college).
BSc Chem, PCPS, now USP Philadelphia.
Hobby: Neurophysiological basis of the Rise and Fall of Civilizations
More-or-less self-taught individual small investor, who started late.
IMHO, Seeking Alpha is THE PREMIUM SITE w/o a peer!
Former Wall Street Veteran who has learned more about macroeconomics and how the world really works since switching to renewable energy last year. Learned from very experienced people, but when I look at screens I feel more like Morpheus from the Matrix. I will not have any positions in anything I write about and remember that everyone has their own time horizon. I have been right too often the past eight years not to be involved in helping people out. You are welcome.